Drugs@FDA: FDA-Approved Drugs
Company: VIATRIS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
NORVASC | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | AB | Yes | No |
NORVASC | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | AB | Yes | No |
NORVASC | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | AB | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
07/31/1992 | ORIG-1 | Approval | Type 1 - New Molecular Entity | STANDARD |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
10/30/2017 | SUPPL-62 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/019787Orig1s062ltr.pdf | |
03/30/2017 | SUPPL-61 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s061lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/019787Orig1s061ltr.pdf | |
03/23/2015 | SUPPL-59 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019787s059lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/019787Orig1s059ltr.pdf | |
07/28/2014 | SUPPL-58 | Manufacturing (CMC) |
Label is not available on this site. |
||
07/24/2013 | SUPPL-57 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/12/2013 | SUPPL-56 | Manufacturing (CMC) |
Label is not available on this site. |
||
11/16/2012 | SUPPL-55 | Manufacturing (CMC) |
Label is not available on this site. |
||
01/07/2013 | SUPPL-54 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019787s054lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/019787Orig1s053,s054ltr.pdf | |
01/07/2013 | SUPPL-53 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019787s053lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/019787Orig1s053,s054ltr.pdf | |
10/31/2011 | SUPPL-52 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s052lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/019787s052ltr.pdf | |
05/09/2011 | SUPPL-47 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s047lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/019787s047ltr.pdf | |
02/17/2010 | SUPPL-45 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019787s045lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/019787s045ltr.pdf | |
10/31/2007 | SUPPL-42 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019787s042lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/019787s042ltr.pdf | |
09/28/2005 | SUPPL-38 | Efficacy-New Indication |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019787s038lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/019787s038ltr.pdf | |
07/13/2005 | SUPPL-37 | Labeling |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019787s037lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/019787s037ltr.pdf | |
05/28/2002 | SUPPL-32 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/19787s032ltr.pdf |
08/20/2003 | SUPPL-31 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/19787slr031ltr.pdf |
01/08/2004 | SUPPL-30 | Efficacy-New Patient Population |
Letter (PDF)
Review |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/19787se5-030ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/019787_S30_NorvascTOC.cfm |
08/13/2001 | SUPPL-29 | Manufacturing (CMC) |
Label is not available on this site. |
||
08/10/2001 | SUPPL-28 | Manufacturing (CMC) |
Label is not available on this site. |
||
12/03/2003 | SUPPL-27 | Labeling |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/19787slr027ltr.pdf |
02/23/2000 | SUPPL-25 | Manufacturing (CMC) |
Label is not available on this site. |
||
09/06/2000 | SUPPL-24 | Manufacturing (CMC)-Control |
Label is not available on this site. |
||
03/14/2000 | SUPPL-23 | Labeling |
Label is not available on this site. |
||
12/15/1999 | SUPPL-22 | Manufacturing (CMC)-Control |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/19787s022_Norvasc.pdf |
02/01/2000 | SUPPL-21 | Manufacturing (CMC)-Packaging |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/19787s021_norvasc.pdf |
07/12/2000 | SUPPL-20 | Efficacy-Labeling Change With Clinical Data |
Letter (PDF)
Review (PDF) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/19787S020LTR.PDF https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/19787-s017_norvase.pdf |
09/07/1999 | SUPPL-19 | Manufacturing (CMC) |
Letter (PDF)
Review |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/19787S019_NORVASC_APPROV.PDF https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/019787-S19_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
06/04/1999 | SUPPL-18 | Manufacturing (CMC) |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/19787-s018_Norvasc.pdf |
07/12/2000 | SUPPL-17 | Labeling |
Letter (PDF)
Review (PDF) |
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2000/19787S020LTR.PDF https://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/19787-s017_norvase.pdf |
03/09/1998 | SUPPL-16 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/98/019787-S16_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
05/16/1997 | SUPPL-15 | Manufacturing (CMC) |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/019787-S15_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
04/18/1997 | SUPPL-14 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/019787-S14_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
01/08/1997 | SUPPL-13 | Labeling |
Review (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/97/19787-S013_Norvasc.pdf |
06/28/1996 | SUPPL-12 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/019787-S12_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
02/07/1996 | SUPPL-11 | Manufacturing (CMC) |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/019787-S11_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
02/08/1996 | SUPPL-10 | Manufacturing (CMC) |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/019787-S10_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
12/05/1995 | SUPPL-9 | Labeling |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019787-S9_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
11/02/1995 | SUPPL-8 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019787-S8_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
06/14/1996 | SUPPL-7 | Efficacy-New Patient Population |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/96/19-787s007_Amlodipine.cfm |
06/19/1995 | SUPPL-6 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019787-S6_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
02/07/1995 | SUPPL-5 | Manufacturing (CMC) |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019787-S5_Norvasc 2.5 mg, 5.0 mg, & 10.0 mg Tablets_toc.cfm |
05/03/1994 | SUPPL-4 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019787-S4_Norvasc Tablets_toc.cfm |
03/03/1994 | SUPPL-3 | Manufacturing (CMC)-Control |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019787-S3_Norvasc_toc.cfm |
01/12/1995 | SUPPL-2 | Labeling |
Review
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/019787-S2_Norvasc Tablets_toc.cfm |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
10/30/2017 | SUPPL-62 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s062lbl.pdf | |
03/30/2017 | SUPPL-61 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/019787s061lbl.pdf | |
03/23/2015 | SUPPL-59 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/019787s059lbl.pdf | |
01/07/2013 | SUPPL-54 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019787s054lbl.pdf | |
01/07/2013 | SUPPL-53 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/019787s053lbl.pdf | |
10/31/2011 | SUPPL-52 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s052lbl.pdf | |
05/09/2011 | SUPPL-47 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s047lbl.pdf | |
02/17/2010 | SUPPL-45 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/019787s045lbl.pdf | |
10/31/2007 | SUPPL-42 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2007/019787s042lbl.pdf | |
09/28/2005 | SUPPL-38 | Efficacy-New Indication | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019787s038lbl.pdf | |
07/13/2005 | SUPPL-37 | Labeling | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019787s037lbl.pdf |
NORVASC
TABLET;ORAL; EQ 2.5MG BASE
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 202553 | ACCORD HLTHCARE |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 078925 | ALKEM |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 078021 | AUROBINDO PHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 076692 | CHARTWELL RX |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 090752 | CHINA RESOURCES |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 077073 | CIPLA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 076719 | COREPHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 078552 | EPIC PHARMA LLC |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 077955 | INVAGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 206367 | INVAGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 078453 | ORBION PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 078414 | OXFORD PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 207821 | POLYGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 077516 | STRIDES PHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 076846 | TEVA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 203245 | UNICHEM |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | No | AB | 078226 | ZYDUS PHARMS USA |
NORVASC | AMLODIPINE BESYLATE | EQ 2.5MG BASE | TABLET;ORAL | Prescription | Yes | AB | 019787 | VIATRIS |
TABLET;ORAL; EQ 5MG BASE
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 202553 | ACCORD HLTHCARE |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 078925 | ALKEM |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 078021 | AUROBINDO PHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 076692 | CHARTWELL RX |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 090752 | CHINA RESOURCES |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 077073 | CIPLA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 076719 | COREPHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 078552 | EPIC PHARMA LLC |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 077955 | INVAGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 206367 | INVAGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 078453 | ORBION PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 078414 | OXFORD PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 207821 | POLYGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 077516 | STRIDES PHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 076846 | TEVA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 203245 | UNICHEM |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | No | AB | 078226 | ZYDUS PHARMS USA |
NORVASC | AMLODIPINE BESYLATE | EQ 5MG BASE | TABLET;ORAL | Prescription | Yes | AB | 019787 | VIATRIS |
TABLET;ORAL; EQ 10MG BASE
TE Code = AB
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 202553 | ACCORD HLTHCARE |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 078925 | ALKEM |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 078021 | AUROBINDO PHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 076692 | CHARTWELL RX |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 090752 | CHINA RESOURCES |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 077073 | CIPLA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 076719 | COREPHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 078552 | EPIC PHARMA LLC |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 077955 | INVAGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 206367 | INVAGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 078453 | ORBION PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 078414 | OXFORD PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 207821 | POLYGEN PHARMS |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 077516 | STRIDES PHARMA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 076846 | TEVA |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 203245 | UNICHEM |
AMLODIPINE BESYLATE | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | No | AB | 078226 | ZYDUS PHARMS USA |
NORVASC | AMLODIPINE BESYLATE | EQ 10MG BASE | TABLET;ORAL | Prescription | Yes | AB | 019787 | VIATRIS |